السوق العالمية لعلاج متلازمة نقل الدم بين التوأمين - اتجاهات الصناعة والتوقعات حتى عام 2028

تحليل السوق والرؤى: سوق علاج متلازمة نقل الدم التوأمية العالمية

من المتوقع أن يشهد سوق علاج متلازمة نقل الدم بين التوأم نموًا في السوق بمعدل 4.50٪ في الفترة المتوقعة من 2021 إلى 2028. يقدم تقرير أبحاث سوق Data Bridge حول سوق علاج متلازمة نقل الدم بين التوأم تحليلاً ورؤى حول العوامل المختلفة التي من المتوقع أن تكون سائدة طوال فترة التنبؤ مع توفير تأثيراتها على نمو السوق. إن الزيادة في انتشار الأمراض النادرة على مستوى العالم تعمل على تصعيد نمو سوق علاج متلازمة نقل الدم بين التوأم.

متلازمة نقل الدم بين التوأمين (TTTS) تشير إلى حالة نادرة وخطيرة تحدث أثناء الحمل عندما يتشارك توأمان متطابقان المشيمة. في المشيمة، تتشكل وصلات غير طبيعية للأوعية الدموية، مما يتسبب في تدفق دم غير متساوٍ بين الأطفال. يميل أحد التوأمين، المعروف باسم المتبرع، إلى الإصابة بالجفاف، بينما يصاب الآخر، المعروف باسم المتلقي، بارتفاع ضغط الدم وينتج مستويات عالية من البول مما يؤدي إلى امتلاء الكيس الأمنيوسي.

The increase in the prevalence of twin-twin transfusion syndrome across the globe acts as one of the major factors driving the growth of the twin-twin transfusion syndrome treatment market. The high risk of heart failure because of fluid overload as one of the complications associated with the syndrome, and increase in the use of ultrasound for diagnosing the condition during pregnancies accelerate the market growth. The increase in the need of drugs for treating the complications caused by the syndrome and rise in in the number of acquisition strategies and company collaborations among manufacturers further influence the market. Additionally, increase in the number of births, developments in healthcare infrastructure, rise in population and high investment positively affect the twin-twin transfusion syndrome treatment market. Furthermore, increase in demand for specific novel treatments extend profitable opportunities to the market players in the forecast period of 2021 to 2028.

On the other hand, high cost associated with the treatment and diagnosis of twin-twin transfusion syndrome is expected to obstruct the market growth. Lack of skilled expertise and limited knowledge are projected to challenge the twin-twin transfusion syndrome treatment market in the forecast period of 2021-2028.

This twin-twin transfusion syndrome treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on twin-twin transfusion syndrome treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth. 

Twin-Twin Transfusion Syndrome Treatment Market Scope and Market Size

The twin-twin transfusion syndrome treatment market is segmented on the basis of symptoms, treatment, mode of administration, distribution channel, and end user. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

• On the basis of symptoms, the twin-twin transfusion syndrome treatment market is segmented into breathlessness, tightness in the abdomen, rapid expansion of abdomen, rapid weight gain, pressure on the stomach, and premature contractions.
• On the basis of treatment, the twin-twin transfusion syndrome treatment market is segmented into surgery, drugs and others.
• On the basis of mode of administration, the twin-twin transfusion syndrome treatment market is segmented into injectable, oral, and others.
• On the basis of distribution channel, the twin-twin transfusion syndrome treatment market is segmented into hospital pharmacies, retail pharmacies and online pharmacies.
• On the basis of end user, the twin-twin transfusion syndrome treatment market is segmented into hospitals, homecare, specialty clinics and others.

Global Twin-Twin Transfusion Syndrome Treatment Market Country Level Analysis

The twin-twin transfusion syndrome treatment market is analyzed and market size information is provided by country, symptoms, treatment, mode of administration, distribution channel, and end user as referenced above.

Countries covered in the global twin-twin transfusion syndrome treatment market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

North America dominates the twin-twin transfusion syndrome treatment market due to the well-established healthcare sector within the region. Asia-Pacific is expected to witness high growth during the forecast period of 2021 to 2028 because of the increase in a number of child births in the area.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

The twin-twin transfusion syndrome treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to the market growth are analyzed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Twin-Twin Transfusion Syndrome Treatment Market Share Analysis

يوفر المشهد التنافسي لسوق علاج متلازمة نقل الدم بين التوأمين تفاصيل حسب المنافس. تتضمن التفاصيل نظرة عامة على الشركة، والبيانات المالية للشركة، والإيرادات المتولدة، وإمكانات السوق، والاستثمار في البحث والتطوير، ومبادرات السوق الجديدة، والحضور العالمي، ومواقع الإنتاج والمرافق، والقدرات الإنتاجية، ونقاط القوة والضعف في الشركة، وإطلاق المنتج، وعرض المنتج ونطاقه، وهيمنة التطبيق. ترتبط نقاط البيانات المذكورة أعلاه فقط بتركيز الشركات على سوق علاج متلازمة نقل الدم بين التوأمين.

اللاعبون الرئيسيون الذين تم تغطيتهم في تقرير سوق علاج متلازمة نقل الدم بين التوأم هم Sanofi وMitsubishi Tanabe Pharma وBrainStorm Cell Limited وViroMed Co., Ltd وIonis Pharmaceuticals وGenervon Biopharmaceuticals, LLC وBiogen وORPHAZYME A/S وOrion وKringle Pharma, Inc. وAquestive Therapeutics وApotex Inc وBausch Health Companies Inc. وNeuralstem, Inc. وImplicit Bioscience وF. Hoffmann-La Roche Ltd وTREEWAY وCYTOKINETICS, INC. وAB Science وAdvanz Pharmaceutical، من بين لاعبين محليين وعالميين آخرين. تتوفر بيانات حصة السوق للعالم وأمريكا الشمالية وأوروبا وآسيا والمحيط الهادئ (APAC) والشرق الأوسط وأفريقيا (MEA) وأمريكا الجنوبية بشكل منفصل. يفهم محللو DBMR نقاط القوة التنافسية ويوفرون تحليلًا تنافسيًا لكل منافس على حدة.

SKU-64398